Skip to content

Study on the application effect of esketamine in pediatric basic anesthesia

Study on the application effect of esketamine in pediatric basic anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122880
Enrollment
Unknown
Registered
2026-04-20
Start date
2026-04-20
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric basic anesthesia

Interventions

Group C:Propofol 1mg / kg
Group E1:Esketamine 0.1 mg / kg
Group E2:Esketamine 0.2 mg / kg
Group E3:Esketamine 0.3 mg / kg
Group E4:Esketamine 0.4 mg / kg

Sponsors

The First Affiliated Hospital of Dali University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 7 Years

Inclusion criteria

Inclusion criteria: 1.Children aged 1-7 years old undergoing elective surgery under general anesthesia ; 2.No serious heart and lung disease or metabolic disease, no history of allergies ; 3.Not taking other drugs that will affect the effect of anesthetic drugs ; 4.American Society of Anesthesiologists physical status rating is I or II.

Exclusion criteria

Exclusion criteria: Nervous system diseases, history of chronic medication, use of analgesic or anti-anxiety drugs within the previous month, family history of genetic problems that suggest avoiding the use of a proposed drug, and parents ' reluctance to participate.

Design outcomes

Primary

MeasureTime frame
Heart rate;Perfusion Index;Pulse Oxygen Saturation;Ramsay Scale;Modified Yale perioperative anxiety scale;Induction period cooperation scale;

Secondary

MeasureTime frame
FLACC scale.;PAED scale;Pittsburgh sleep quality index questionnaire;

Countries

China

Contacts

Public ContactRongxin Luo

The First Affiliated Hospital of Dali University

luorongxin121@163.com+86 136 1942 3453

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026